Oncology
Circa 1600 BCE — Edwin Smith Papyrus, Ancient Egypt
Glioma, a tumor arising from the supportive glial cells of the brain and spinal cord, occupied a particularly mysterious position in the history of medicine because the brain itself was long considered either sacred, inert, or so complex as to defy surgical intervention. Ancient and medieval physicians who encountered patients with progressive neurological deterioration rarely suspected an internal growth as the cause, attributing such decline instead to supernatural forces, humoral imbalance, or diseases of the spirit. The gradual recognition of intracranial tumors as distinct pathological entities unfolded over centuries of painstaking anatomical, surgical, and eventually microscopic investigation.
Historical Narrative
The earliest written references to conditions that may have represented brain tumors appeared in ancient Mesopotamian and Egyptian texts, though the descriptions were thoroughly embedded in religious and demonological frameworks. The Edwin Smith Papyrus, dating to roughly 1600 BCE, documented careful observations of head injuries and their consequences but did not distinguish between traumatic and neoplastic causes of neurological change. Hippocratic authors writing between the fifth and fourth centuries BCE described cases of headache, progressive weakness, and altered consciousness that they attributed to an excess of black bile accumulating within the skull, and they prescribed dietary modification, purging, and cautious trephination in some instances.
Galen of Pergamon provided the most influential ancient discussion of what he called onkoi, or swellings, of the brain, classifying them among other tumors of the body according to his humoral system. Galenic thought held that such growths resulted from the stagnation and corruption of humors within cranial tissues, and treatment focused on systemic humoral correction rather than any direct intervention on the brain itself. This framework shaped European and Islamic medical thought for over a millennium, with physicians such as Ibn Sina and later Guy de Chauliac discussing cranial swellings in essentially Galenic terms.
The anatomical revolution of the sixteenth century began to shift understanding. Vesalius and his successors produced detailed illustrations of brain structure, and occasional autopsy reports documented discrete masses within cranial cavities. The seventeenth and eighteenth centuries saw increasing autopsy-based case documentation, with physicians such as Giovanni Battista Morgagni systematically correlating clinical symptoms with postmortem findings. Morgagni's foundational 1761 work, De Sedibus et Causis Morborum, included descriptions of intracranial masses and represented an early effort to localize disease within specific anatomical structures.
The microscopic era of the nineteenth century transformed the classification of brain tumors fundamentally. Rudolf Virchow, working in the 1850s, introduced the concept of cellular pathology and became the first to describe and name neuroglia, the supportive cells of the nervous system. Virchow also identified tumors arising from glial tissue and established the term glioma in the medical literature, providing the first histological framework for distinguishing these tumors from other intracranial masses. His work made possible a systematic, cell-based taxonomy that subsequent pathologists refined over decades.
Surgical intervention on brain tumors became a realistic, if enormously dangerous, proposition in the late nineteenth century. London surgeon William Macewen successfully operated on intracranial masses in the 1870s and 1880s, relying on careful clinical localization. American neurosurgeon Harvey Cushing, working in the early twentieth century, brought systematic rigor to brain tumor surgery, developing specialized techniques and producing exhaustive pathological records of hundreds of cases. Cushing's monumental 1926 monograph, co-authored with Percival Bailey, provided the first comprehensive histological classification of gliomas, distinguishing multiple subtypes by cellular appearance and correlating them with clinical outcomes. Bailey and Cushing's classification remained the foundation of neuropathology for decades and marked the beginning of the modern scientific understanding of these tumors.
Key Historical Figures
Historical narrative only — this page describes how Glioma was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.